• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 - 2020年新英格兰地区初级保健中堕胎服务的障碍:一项定性研究

Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.

作者信息

Lee Charlotte M, Johns Sarah L, Stulberg Debra B, Allen Rebecca H, Janiak Elizabeth

机构信息

Warren Alpert Medical School of Brown University, Providence, RI, USA.

Brigham and Women's Hospital, Department of Obstetrics and Gynecology, Boston, MA, USA.

出版信息

Contraception. 2023 Jan;117:39-44. doi: 10.1016/j.contraception.2022.08.001. Epub 2022 Aug 12.

DOI:10.1016/j.contraception.2022.08.001
PMID:35970423
Abstract

OBJECTIVE

To assess barriers to and facilitators of abortion provision among abortion-trained primary care providers.

STUDY DESIGN

We conducted 21 qualitative in-depth interviews with 20 abortion-trained family physicians and one internal medicine physician in five New England states. We dual-coded interviews, using a consensus method to agree upon final coding schema. Through iterative dialogue, using an inductive content analysis approach, we synthesized the themes and identified patterns within each domain of inquiry.

RESULTS

The most commonly reported barriers were a lack of organizational support, the Hyde Amendment, which prevents the use of federal funds for most abortion care, and the mifepristone Risk Evaluation and Mitigation Strategy, a federal regulation which prohibits routine mifepristone pharmacy dispensing. The logistical barriers created by these policies require cooperation from additional stakeholders, creating more opportunities for abortion stigma and moral opposition to arise. Other salient barriers included inter-specialty tension (particularly with obstetrician-gynecologists), perceived need for pre-abortion ultrasound, absence of a clinician support network, and lack of knowledge of existing resources for establishing abortion care in primary care.

CONCLUSIONS

Increased abortion provision in primary care is one of many necessary responses to the human rights crisis produced by the Dobbs decision. Eliminating the Hyde Amendment and ending federal regulations restricting pharmacy dispensing of mifepristone are key interventions to address barriers to primary care abortion provision. Building interspecialty partnerships between family medicine and OB/GYN and spreading awareness of the evidence-based ultrasound-as-needed protocol and other educational resources are also likely to increase primary care abortion access.

IMPLICATIONS

By exploring barriers to and facilitators of primary care abortion provision, this study outlines a targeted approach to support increased access to abortions. In states with legal abortion post-Roe, it is important that motivated and trained primary care providers can offer abortions, rather than referring patients to overburdened specialty clinics.

摘要

目的

评估接受过堕胎培训的初级保健提供者在提供堕胎服务方面的障碍和促进因素。

研究设计

我们对新英格兰五个州的20名接受过堕胎培训的家庭医生和1名内科医生进行了21次定性深入访谈。我们对访谈进行了双重编码,采用共识方法确定最终编码方案。通过反复对话,采用归纳式内容分析法,我们在每个调查领域内综合了主题并识别出模式。

结果

最常报告的障碍包括缺乏组织支持、《海德修正案》(该修正案禁止使用联邦资金进行大多数堕胎护理)以及米非司酮风险评估和缓解策略(一项联邦法规,禁止米非司酮在药房常规配药)。这些政策造成的后勤障碍需要其他利益相关者的合作,从而产生了更多堕胎污名化和道德反对出现的机会。其他显著障碍包括专科间的紧张关系(特别是与妇产科医生之间)、认为堕胎前需要进行超声检查、缺乏临床医生支持网络以及对在初级保健中建立堕胎护理的现有资源缺乏了解。

结论

增加初级保健中的堕胎服务是对多布斯裁决引发的人权危机的众多必要应对措施之一。消除《海德修正案》并终止限制米非司酮药房配药的联邦法规是解决初级保健堕胎服务障碍的关键干预措施。在家庭医学和妇产科之间建立跨专科伙伴关系,并传播基于证据的按需超声检查方案及其他教育资源的意识,也可能会增加初级保健中堕胎服务的可及性。

启示

通过探索初级保健堕胎服务的障碍和促进因素,本研究概述了一种有针对性的方法来支持增加堕胎服务的可及性。在罗诉韦德案后堕胎合法的州,有积极性且受过培训的初级保健提供者能够提供堕胎服务,而不是将患者转诊至负担过重的专科诊所,这一点很重要。

相似文献

1
Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.2019 - 2020年新英格兰地区初级保健中堕胎服务的障碍:一项定性研究
Contraception. 2023 Jan;117:39-44. doi: 10.1016/j.contraception.2022.08.001. Epub 2022 Aug 12.
2
Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.通过药房配发米非司酮扩大药物流产的可及性:来自伊利诺伊州的初级保健视角。
Contraception. 2021 Jul;104(1):98-103. doi: 10.1016/j.contraception.2021.03.022. Epub 2021 Mar 26.
3
Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.将米非司酮纳入加拿大首都的初级保健:医疗流产准入项目的多方法探索。
Contraception. 2022 May;109:37-42. doi: 10.1016/j.contraception.2022.01.002. Epub 2022 Jan 11.
4
Abortion Stigma as a Barrier to Mifepristone Use among Obstetrician-Gynecologists in Alabama for Early Pregnancy Loss.阿拉巴马州妇产科医生在早期妊娠丢失中使用米非司酮时的堕胎污名作障碍。
South Med J. 2024 Aug;117(8):504-509. doi: 10.14423/SMJ.0000000000001717.
5
Barriers and Facilitators to the Implementation of First Trimester Medical Abortion With Mifepristone in the Province of Québec: A Qualitative Investigation.魁北克省实施米非司酮早期药物流产的障碍和促进因素:一项定性研究。
J Obstet Gynaecol Can. 2020 May;42(5):576-582. doi: 10.1016/j.jogc.2019.10.037. Epub 2020 Jan 8.
6
"We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.“我们有权利,但我们却无法获得药物流产服务”:探索澳大利亚患者获取药物流产服务的体验。
Contraception. 2020 Apr;101(4):256-260. doi: 10.1016/j.contraception.2019.12.008. Epub 2020 Jan 9.
7
Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.探索米非司酮风险评估与降低策略(REMS)对药物流产纳入美国家庭医学初级保健诊所的影响✰,✰✰ 。
Contraception. 2022 May;109:19-24. doi: 10.1016/j.contraception.2022.01.017. Epub 2022 Feb 4.
8
US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.美国临床医生如何看待米非司酮法规对初级保健中药物流产和早期妊娠丢失护理的可及性的看法。
Contraception. 2021 Jul;104(1):92-97. doi: 10.1016/j.contraception.2021.04.017. Epub 2021 Apr 25.
9
Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives.孟加拉国的非诊所和自我管理堕胎:月经调节提供者的观点。
Reprod Health. 2021 Mar 25;18(1):69. doi: 10.1186/s12978-021-01123-w.
10
Family Physicians' Barriers and Facilitators in Incorporating Medication Abortion.家庭医生在纳入药物流产方面的障碍和促进因素。
J Am Board Fam Med. 2022 May-Jun;35(3):579-587. doi: 10.3122/jabfm.2022.03.210266.

引用本文的文献

1
Spatial Disparities in Mifepristone Use for Early Miscarriage and Induced Abortion Among Obstetrician-Gynecologists Practicing in Massachusetts.在马萨诸塞州执业的妇产科医生中,米非司酮用于早期流产和人工流产的空间差异。
Womens Health Rep (New Rochelle). 2024 Oct 4;5(1):765-774. doi: 10.1089/whr.2024.0085. eCollection 2024.
2
Telemedicine Abortion in Primary Care: An Exploration of Patient Experiences.基层医疗中的远程医疗流产:对患者体验的探索。
Ann Fam Med. 2024 Jan-Feb;22(1):19-25. doi: 10.1370/afm.3058.
3
Barriers and enablers to nurse practitioner implementation of medication abortion in Canada: A qualitative study.
在加拿大,护士从业者实施药物流产的障碍和促进因素:一项定性研究。
PLoS One. 2023 Jan 26;18(1):e0280757. doi: 10.1371/journal.pone.0280757. eCollection 2023.